Latest Breaking News On - டெசிபல் சிகிச்சை - Page 3 : comparemela.com

Director of Decibel Therapeutics, Inc (NASDAQ:DBTX), Foy Matthew, buys 150,000 shares worth ,700,000

Director of Decibel Therapeutics, Inc (NASDAQ:DBTX), Foy Matthew, buys 150,000 shares worth ,700,000
empowerednews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empowerednews.net Daily Mail and Mail on Sunday newspapers.

Foy matthewDecibel therapeutics incDirector of decibel therapeutics incDecibel therapeuticsStatement of changes in beneficial ownershipGeorge danielsFriday februaryஃபாய் மேத்யூடெசிபல் சிகிச்சை இன்க்இயக்குனர் ஆஃப் டெசிபல் சிகிச்சை இன்க்டெசிபல் சிகிச்சைஅறிக்கை ஆஃப் மாற்றங்கள் இல் நன்மை பயக்கும் ஓநர்‌ஶிப்ஜார்ஜ் டேனியல்ஸ்வெள்ளி பிப்ரவரி

(ATEX), (BBIO) - The Past Week s Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More

(ATEX), (BBIO) - The Past Week s Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Richard millerFiserv incOncorus incCorvus pharmaceuticals incHealth corpKnight incBridgebio pharma incDecibel therapeutics incTalis biomedical corpUnited states steel corporationNeximmune incAnterix incBancshares incMolecular templates incNu skin enterprises incProthena corporation

Decibel Therapeutics Announces Pricing of Initial Public Offering

Decibel Therapeutics Announces Pricing of Initial Public Offering BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the pricing of its initial public offering of 7,062,000 shares of its common stock at a price to the public of $18.00 per share. All of the shares of common stock are being offered by Decibel. In addition, Decibel has granted the underwriters a 30-day option to purchase up to an additional 1,059,300 shares of common stock at the public offering price, less underwriting discounts and commissions.

United statesJulie seidelMatthew corcoranExchange commissionBroadridge financial solutionsStern investor relations incCitigroup global markets incSyndicate departmentDecibel therapeuticsNasdaq global select marketIsland avenueOne federal streetInvestor relationsஒன்றுபட்டது மாநிலங்களில்ஜூலி சீடல்மேத்யூ கோர்கோரன்

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesCampbell edwards conroyRaymondc kubackiSarah ashbyPsychemedics corporationDecibel therapeutics incWilmer cutler pickering hale dorrTakeda pharmaceutical company ltdVice presidentDecibel therapeuticsTakeda pharmaceutical companyCampbell edwardsWilmer cutler pickering haleGeneral counselFederal reserve banksPrivate securities litigation reform act